The place of leukopenia in leukocyte pathology
Changes in the white blood cell system are divided into three main groups.
First, these are quantitative deviations per unit volume of blood: an increase (leukocytosis) or a decrease (leukopenia).
Second, disorders in the ratio of different cell types. This includes relative and absolute cytoses ("-philias") and cytopenias, as well as shifts in the leukocyte formula to the left (an increase in the number of immature forms) or to the right (predominance of mature and overmature cells).
Third, the biological properties of the leukocytes themselves may change: their biochemical, biophysical, and structural-functional characteristics.
Clinical and diagnostic significance
Leukopenia, like leukocytosis, rarely acts as an independent disease. It is a secondary response to the development of pathology. With the successful treatment of the underlying disease, blood parameters (total cell count, ratio of their mature forms, absence of signs of degeneration) return to normal. Special treatment of the blood changes themselves in such cases is not required.
Nevertheless, quantitative and qualitative deviations are of immense diagnostic value. They allow the physician to:
- Record the onset of the pathological process.
- Confirm the presence of pathology.
- Monitor the dynamics of the disease course.
It is extremely important to differentiate reactive leukopenias from leukemias — independent neoplastic diseases with their own causes and mechanisms of development that require specific treatment.
Classification and causes
Globally, two main forms of leukopenia are distinguished: primary (congenital or hereditary) and secondary (acquired).
In the vast majority of cases, primary forms manifest as neutropenias. These include congenital aleukia, familial and periodic hereditary neutropenias, as well as lazy leukocyte syndrome (Chediak-Higashi syndrome).
Secondary leukopenias occur under the influence of multiple factors, which are classified by their origin:
- Biological: infectious agents (influenza, measles, hepatitis viruses, typhoid fever and rickettsial pathogens), as well as autoaggressive immunoglobulins and immunocytes (for example, in systemic lupus erythematosus).
- Chemical: toxic substances (benzene, insecticides) and medications (sulfonamides, barbiturates, antimetabolites, chloramphenicol, isoniazid, alkylating agents, antitumor antibiotics).
- Physical: mechanical trauma and exposure to low doses of ionizing radiation.
Mechanisms of leukopenia development
The decrease in the number of leukocytes in the blood is realized through one or more pathogenetic mechanisms:
- Impairment or suppression of leukopoiesis. A decrease in cell production in the hematopoietic tissue.
- Excessive destruction of leukocytes. Occurs directly in the vascular bed or hematopoietic organs.
- Redistribution of leukocytes. Accumulation of cells in certain areas of the vascular bed, leading to a decrease in their count in the peripheral blood.
- Loss of leukocytes. Elimination of cells from the body.
- Hemodilution. Fluid thinning of the blood. This is the so-called relative leukopenia, in which the absolute leukocyte content in the body remains normal, but their concentration drops.
Details: why is leukopoiesis suppressed?
Suppression of leukocyte production is one of the leading mechanisms. It can be triggered by genetic defects (anomalies in genes controlling cell maturation).
Disorders of neurohumoral regulation also become a cause: hypothyroid states, hypocorticism, decreased levels of leukotrienes, or a drop in the sensitivity of leukocyte lineage cells to them.
Frequently, leukopoiesis suffers due to a lack of components necessary for hematopoiesis: significant deficiency of proteins, amino acids, phospholipids, as well as a shortage of folic acid and vitamin B12 (cyanocobalamin).
The factors disrupting leukopoiesis are classified by origin (endogenous and exogenous) and by character (infectious and non-infectious). By nature, they can be physical exposures (small doses of radiation), chemical agents (moderate oxygen deficit, drug effects), or biological agents (microbes, immune complexes).
For comparison: mechanisms of leukocytosis
Unlike leukopenia, an increase in the number of leukocytes (leukocytosis) develops through different scenarios. Its main mechanisms include:
- Stimulation of leukopoiesis and active release of cells into the peripheral blood.
- Redistribution of leukocytes.
- Hemoconcentration (thickening of the blood).
- Tumor activation (in leukemias and hemosarcomas).
Normal leukopoiesis is activated by increasing the level of stimulators (e.g., colony-stimulating factors — CSFs) or by decreasing the activity of proliferation inhibitors and cell maturation inducers.
Briefly: answers to topical questions
What are the mechanisms of development and causes of redistributive leukopenia?
Redistributive leukopenia develops as a result of inadequate distribution of cells within the vascular bed or their retention in certain organs.
Main causes and mechanisms:
- Anaphylactic shock — causes pathological redistribution of leukocytes directly within the vascular bed.
- Hypersplenism — leads to the sequestration of cells in organs (for example, in liver cirrhosis).
- Action of glucocorticoids — decreases the level of lymphocytes, monocytes, eosinophils, and basophils in the blood due to the redistribution of these cells from the circulating bloodstream into lymphoid tissue.
At what absolute leukocyte count (per 1 liter of blood) is leukopenia diagnosed in adults?
Leukopenia is diagnosed when the absolute leukocyte count in peripheral blood is less than 4 × 10⁹/L. When assessing toxic effects on the blood, a decrease in the leukocyte level below the lower limit of normal down to 3.0 × 10⁹/L is considered grade 1 toxicity, and a drop below 1.0 × 10⁹/L is considered the most severe, grade 4 toxicity.
To remember the mechanisms of leukopenia, use the "Five P's" rule: Production drop (suppression), Pathology/Damage (destruction), Redistribution, Passage/Loss, Plasma (hemodilution).
Class and exam questions
Does Leukopenia Require Standalone Treatment?
As a rule, no. This is a secondary response, and with the successful treatment of the underlying disease, blood parameters normalize on their own.
How Does Reactive Leukopenia Differ from Leukemia?
Reactive changes are secondary and reversible. Leukemias are independent neoplastic diseases of the hematopoietic system that require specific therapy.
What Is Relative Leukopenia?
This is a condition that occurs during hemodilution (blood thinning). The total number of leukocytes in the body remains normal, but their concentration per unit volume decreases.
What else to study on this topic
- Shifts in the leukocyte formula (left and right)
- Chediak-Higashi syndrome (lazy leukocyte syndrome)
- Changes in the biological properties of leukocytes
- The role of colony-stimulating factors (CSFs) in the regulation of leukopoiesis
Master the entire topic in the "Pathophysiology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Leukopenias" and another 4,913 pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 135 video lessons on the subject
Other topics in "Chapter 21. Typical Pathology Forms of the Blood System"
Free video lessons: pathophysiologyShort lessons with lecture notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.